Chengdu Kanghua Biological Products Co., Ltd.

XSEC:300841 Stock Report

Market Cap: CN¥7.5b

Chengdu Kanghua Biological Products Future Growth

Future criteria checks 2/6

Chengdu Kanghua Biological Products is forecast to grow earnings and revenue by 18% and 15.4% per annum respectively. EPS is expected to grow by 17.6% per annum. Return on equity is forecast to be 16.8% in 3 years.

Key information

18.0%

Earnings growth rate

17.6%

EPS growth rate

Biotechs earnings growth43.6%
Revenue growth rate15.4%
Future return on equity16.8%
Analyst coverage

Low

Last updated22 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300841 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,403889N/A9415
12/31/20252,145794N/A6485
12/31/20241,883705N/A7505
9/30/20241,648546414562N/A
6/30/20241,684568491628N/A
3/31/20241,611553523656N/A
12/31/20231,577509417574N/A
9/30/20231,382484233440N/A
6/30/20231,42153172384N/A
3/31/20231,458568-85324N/A
1/1/20231,447598-224195N/A
9/30/20221,567729-246138N/A
6/30/20221,400893-31083N/A
3/31/20221,322864-27482N/A
1/1/20221,292829-185130N/A
9/30/2021993648-20397N/A
6/30/20211,13647835213N/A
3/31/20211,119444158302N/A
12/31/20201,039408234370N/A
9/30/20201,085442237327N/A
6/30/2020739285188263N/A
3/31/2020581216123166N/A
12/31/2019555187159183N/A
9/30/2019425101170189N/A
12/31/20185591542357N/A
12/31/201726274N/A90N/A
12/31/2016937N/A3N/A
12/31/20157112N/A7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300841's forecast earnings growth (18% per year) is above the savings rate (2.8%).

Earnings vs Market: 300841's earnings (18% per year) are forecast to grow slower than the CN market (25.9% per year).

High Growth Earnings: 300841's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300841's revenue (15.4% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 300841's revenue (15.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300841's Return on Equity is forecast to be low in 3 years time (16.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y